Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
LPS-EK (LPS from E. coli K12) Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS... 2021 Nat Commun. Jones N. et al. DOI: 10.1038/s41467-021-21461-4
LPS-EB (LPS from E. coli O111:B4) Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS... 2021 Nat Commun. Jones N. et al. DOI: 10.1038/s41467-021-21461-4
LPS-EK (LPS from E. coli K12) Short chain fatty acids inhibit endotoxin-induced uveitis and inflammatory re... 2021 Exp Eye Res. Chen N. et al. DOI: 10.1016/j.exer.2021.108520
Peptide M / Agarose Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with... 2021 Glycoconj J. Verathamjamras C. et al. DOI: 10.1007/s10719-021-09978-8
ODN 2006 (ODN 7909) Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implica... 2021 Blood Cancer J. Lu P. et al. DOI: 10.1038/s41408-021-00429-z
Puromycin Naked mole rat TRF1 safeguards glycolytic capacity and telomere replication u... 2021 Sci Adv. Augereau A. et al. DOI: 10.1126/sciadv.abe0174
Primocin™ Naked mole rat TRF1 safeguards glycolytic capacity and telomere replication u... 2021 Sci Adv. Augereau A. et al. DOI: 10.1126/sciadv.abe0174
Hygromycin B Gold Naked mole rat TRF1 safeguards glycolytic capacity and telomere replication u... 2021 Sci Adv. Augereau A. et al. DOI: 10.1126/sciadv.abe0174
PMA LACC1 deficiency links juvenile arthritis with autophagy and metabolism in ma... 2021 J Exp Med. Omarjee O. et al. DOI: 10.1084/jem.20201006
CL097 Low immune activation in early pregnancy is associated with preterm but not s... 2021 Clin Infect Dis. Mdletshe N. et al. DOI: 10.1093/cid/ciab151
CFA IL10- and IL35-Secreting MutuDC Lines Act in Cooperation to Inhibit Memory T ... 2021 Front. Immunol. Koga M.M. et al. DOI: 10.3389/fimmu.2021.607315
Ruxolitinib Transient prenatal ruxolitinib treatment suppresses astrogenesis during devel... 2021 Sci Rep. Lee H.C. et al. DOI: 10.1038/s41598-021-83222-z
Plasmocin™ - Mycoplasma Elimination Reagent AraC-FdUMP[10] (CF10) is a next generation fluoropyrimidine with potent antit... 2021 Mol Cancer Res. Haber A.O. et al. DOI: 10.1158/1541-7786.MCR-20-0985
Plasmocin™ - Mycoplasma Elimination Reagent PLA2R1 promotes DNA damage and inhibits spontaneous tumor formation during ag... 2021 Cell Death Dis. Huna A. et al. DOI: 10.1038/s41419-021-03468-3
LPS-EB (LPS from E. coli O111:B4) IL-22 promotes the formation of a MUC17 glycocalyx barrier in the postnatal s... 2021 Cell Rep. Layunta E. et al. DOI: 10.1016/j.celrep.2021.108757
IL-2 Reporter HEK 293 Cells Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 ... 2020 Antimicrob Agents Chemother. Sorensen E.S. et al. DOI: 10.1128/AAC.00888-20
IL-2 Reporter HEK 293 Cells Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor t... 2020 Oncoimmunology Kujawski M. et al. DOI: 10.1080/2162402X.2020.1724052
LPS-EK (LPS from E. coli K12) Identification of anti‐inflammatory vesicle‐like nanoparticles in honey. 2021 J. Extracell. Vesicles Chen X. et al. DOI: 10.1002/jev2.12069
Plasmocin™ - Mycoplasma Elimination Reagent NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy 2021 Cancers (Basel). Sanghvi V.R. et al. DOI: 10.3390/cancers13040639
pFUSE-hIgG1-Fc Targeting galectin-3 with a high-affinity antibody for inhibition of high-gra... 2021 Sci Rep. Stasenko M. et al. DOI: 10.1038/s41598-021-82686-3

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty